<?xml version="1.0" encoding="UTF-8"?>
<p id="Par15">High risk features of our subject population were similar to those previously reported for HRNB population studies with regards to stage, 
 <italic>MYCN</italic>, histology, ploidy and induction response
 <sup>
  <xref ref-type="bibr" rid="CR5">5</xref>,
  <xref ref-type="bibr" rid="CR20">20</xref>
 </sup>. All subjects enrolled in the ITT populations were compliant with study visits and evaluations, with 98% of subjects receiving &gt;80% of DFMO doses over the two years of treatment.
</p>
